Data di Pubblicazione:
2018
Abstract:
Our data confirm that pregnant women with PVhave an increased risk of fetal loss. The high rate of advanced miscar-riage, related to the presence ofJAK2V617F mutation, seems to bereduced by anti-thrombotic therapy. The correct use of vene-section has to be established in this setting of patients. Due to the rar-ity of this condition, collaborative studies are required to better clarifythe best management of pregnancy in PV
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
pregnancy, jak2, polycythemia
Elenco autori:
Bertozzi, I; Rumi, E; Cavalloni, C; Cazzola, M; Fabris, F; Randi, Ml
Link alla scheda completa:
Pubblicato in: